Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 39 results:
Author Title Type [ Year] Filters: Author is Terpos, Evangelos [Clear All Filters]
Paget's disease of bone: emphasis on treatment with zoledronic acid..
Expert Rev Endocrinol Metab. 4(5), 423-434.
(2009). RANKL inhibition for the management of patients with benign metabolic bone disorders..
Expert Opin Investig Drugs. 18(8), 1085-102.
(2009). Transient secondary hyperparathyroidism following intravenous infusion of zoledronic acid..
Support Care Cancer. 17(10), 1329-30.
(2009). Dual-energy X-ray absorptiometry and quantitative ultrasound in patients with Paget's disease of bone before and after treatment with zoledronic acid: association with serum bone markers and Dickkopf-1..
J Clin Densitom. 13(2), 190-6.
(2010). The effect of teriparatide on serum Dickkopf-1 levels in postmenopausal women with established osteoporosis..
Clin Endocrinol (Oxf). 72(6), 752-7.
(2010). Profound hypocalcemia following effective response to zoledronic acid treatment in a patient with juvenile Paget's disease..
J Bone Miner Metab. 28(6), 706-12.
(2010). Serum homocysteine, folate and vitamin B12 in patients with Paget's disease of bone: the effect of zoledronic acid..
J Bone Miner Metab. 28(3), 314-9.
(2010). Normal bone turnover markers in a patient with active Paget's disease of bone: response to treatment with zoledronic acid..
Endokrynol Pol. 63(4), 312-5.
(2012). Is serum IL-17A a useful systemic biomarker in patients with Langerhans cell histiocytosis?.
Mol Ther. 20(1), 6-7.
(2012). Serum osteoprotegerin, RANKL, and Dkk-1 levels in adults with Langerhans cell histiocytosis..
J Clin Endocrinol Metab. 97(4), E618-21.
(2012). Adipocytokines and cytokeratin-18 in patients with nonalcoholic fatty liver disease: Introduction of CHA index..
Ann Hepatol. 12(5), 749-57.
(2013). Helicobacter pylori infection in patients with nonalcoholic fatty liver disease..
Metabolism. 62(1), 121-6.
(2013). A novel noninvasive index for nonalcoholic steatohepatitis: a pilot study..
Biomarkers. 18(7), 607-13.
(2013).
(2014).
Circulating semaphorin-4D and plexin-B1 levels in postmenopausal women with low bone mass: the 3-month effect of zoledronic acid, denosumab or teriparatide treatment..
Expert Opin Ther Targets. 19(3), 299-306.
(2015).
(2015).
(2015). Bortezomib-based triplets are associated with a high probability of dialysis independence and rapid renal recovery in newly diagnosed myeloma patients with severe renal failure or those requiring dialysis..
Am J Hematol. 91(5), 499-502.
(2016). Circulating sclerostin and Dickkopf-1 levels in patients with nonalcoholic fatty liver disease..
J Bone Miner Metab. 34(4), 447-56.
(2016). Clinical vertebral fractures following denosumab discontinuation..
Endocrine. 54(1), 271-272.
(2016). Cardiac and renal complications of carfilzomib in patients with multiple myeloma..
Blood Adv. 1(7), 449-454.
(2017). Evaluation of the Revised International Staging System in an independent cohort of unselected patients with multiple myeloma..
Haematologica. 102(3), 593-599.
(2017). Hematologic and renal improvement of monoclonal immunoglobulin deposition disease after treatment with bortezomib-based regimens..
Leuk Lymphoma. 58(8), 1832-1839.
(2017). Low periostin levels in adult patients with Langerhans cell histiocytosis are independently associated with the disease activity..
Metabolism. 71, 198-201.
(2017). Periostin and sclerostin levels in juvenile Paget's disease..
Clin Cases Miner Bone Metab. 14(2), 269-271.
(2017).